From The Dealing Desk – Aspen (APN) Analysis
Sidney Launspach
ALSI Mentor & Portfolio ManagerSidney is a professional derivatives trader and portfolio manager with a background in economics, having completed his degree in BCom Economics in 2006. He has experienced both prosperous and challenging times in the markets over the past 11 years, which has shaped his trading strategy to generate maximum revenue during uncertain times. He believes that being innovative and adaptable is key to success in the world of trading.
Aspen Pharmaceuticals is a share that has gone sideways to lower over the past eighteen months. This share is publishing its results on Thursday 14 September and should give us an indication of the “health” of the share. The expectation is for an increase in headline earnings of between 18% and 22%.
The chart is shown below and as you can see, the share has made some higher lows of late. The share price is making a triangle pattern that looks like it could break up if the results satisfy the market. This is a share that could move somewhat in the next few days.
Levels to consider:
- 295 00 break above would lead to further upside
- 280 00 break below should be viewed as negative for the share
A few more shares to study at home, that might have seen the worst of this technical recession, and should be placed on a watch-list are the following:
- Remgro
- Steinhoff
- MTN
- Woolies
- Imperial
- Barloworld
- Mediclinics
- Sanlam
Next time
We’ll be having a look at global indices and trends in the financial markets worlwide.
Sidney Launspach
ALSI Mentor & Portfolio ManagerSidney is a professional derivatives trader and portfolio manager with a background in economics, having completed his degree in BCom Economics in 2006. He has experienced both prosperous and challenging times in the markets over the past 11 years, which has shaped his trading strategy to generate maximum revenue during uncertain times. He believes that being innovative and adaptable is key to success in the world of trading.
Comments